2nd Apr 2007 07:04
Hutchison China Meditech Limited02 April 2007 Hutchison China MediTech Limited (AIM: HCM) Board Change London: Monday, 2 April 2007: The Board of Hutchison China MediTech Limited("Chi-Med") today announces that Mr. Stephen Yeung who has been a Non-executiveDirector of Chi-Med since April 2006 retired with effect from 1 April 2007. Simon To, Chairman said: "We would like to express our deep appreciation for allhis contribution to Chi-Med and wish him well." Stephen Yeung was appointed to the Chi-Med Board last year as a representativeof Hutchison Whampoa Limited's interests. Ends Enquiries Chi-Med Telephone: +852 2121 8200 Christian Hogg, CEO Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571 Anthony Carlisle +44 (0) 7973 611 888 Yvonne Alexander +44 (0) 7866 610 682 About Chi-Med Chi-Med is the holding company of a pharmaceutical and healthcare group basedprimarily in China and was admitted to trading on the Alternative InvestmentMarket of the London Stock Exchange in May 2006. Chi-Med is focused onresearching, developing, manufacturing, and selling pharmaceuticals, healthsupplements and other consumer health and personal care products derived fromTraditional Chinese Medicine and botanical ingredients. Chi-Med is majority owned by Hutchison Whampoa Limited, an internationalcorporation listed on the Main Board of The Stock Exchange of Hong Kong Limited. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hutchmed